Nurse Practitioner in North Plainfield, NJ Accepting Medicare

5 Nurse Practitioner nurses found. Showing 1 - 5

Olaitan Babarinde, Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 25 Craig Pl, North Plainfield, NJ 07060 Phone: 908-791-9993    Fax: 908-791-9995

Mrs. Pushpam Mary William, NP Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 719 Route 22 W, North Plainfield, NJ 07060 Phone: 908-561-4300

Stephanie A. Rodriguez, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 43 Pearl St, North Plainfield, NJ 07060 Phone: 908-822-9700

Mrs. Myriam N Paredes, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 43 Pearl St, North Plainfield, NJ 07060 Phone: 908-822-9700

Rachel Snyder, NP Nurse Practitioner - Acute Care Medicare: Medicare Enrolled Practice Location: 309 Lawrence Ave, North Plainfield, NJ 07063 Phone: 098-581-3967

News Archive

Face mask mandates reduced COVID-19 case rates, hospitalizations and deaths in Kansas

Despite facing cultural and political pushback, the evidence remains clear: Face masks made a difference in Kansas.

Dendreon plans to make PROVENGE available in Europe

Dendreon Corporation today announced that it plans to make PROVENGE (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.

Scientists show p300 protein may stop MDS from developing into leukemia

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML). The study was published in the journal Leukemia.

Skinvisible granted patent in Australia for polymer delivery system

Skinvisible, Inc. the developers of Invisicare, a polymer delivery system that enhances topically applied products, has been granted a comprehensive patent in Australia.

Drug sensitivity of hepatocellular cancer cells may provide new insights on tumor biology

Oncotarget published "Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells" which reported that this study aimed to investigate whether Hepatocellular Cancer (HCC) cells cultured in more native conditions have an altered phenotype and drug sensitivity compared to those cultured in standard conditions.

Read more Medical News

› Verified 3 days ago